Can a common drug stop dangerous bleeding in pregnancy?
NCT ID NCT05840471
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether tranexamic acid, a drug that helps blood clot, can safely stop vaginal bleeding in pregnant women with abruptio placenta (when the placenta separates from the womb too early). 116 women at 24 weeks or more of pregnancy received either the drug or a placebo. Researchers tracked bleeding control, pregnancy length, and newborn health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tranexamic acid
What this could lead to
If successful, this could provide a safe way to reduce heavy bleeding in pregnant women with abruptio placenta, potentially improving outcomes for mothers and babies.
What could go wrong
This is a small, completed trial with 116 participants. The results may not apply to all women, and tranexamic acid carries risks like blood clots. More research is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VAGINAL BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shahla Kareem Alalaf
Erbil, Kurdistan Region, 44001, Iraq